Reusable manual resuscitators market seen climbing to $1.68 billion by 2030

The reusable manual resuscitators market is projected to grow from $1.07 billion in 2025 to $1.17 billion in 2026, then reach $1.68 billion by 2030, according to The Business Research Company. The report points to rising respiratory disease, more surgeries, and higher healthcare spending as the main forces behind demand for portable emergency ventilation devices.

Why it matters: - Reusable manual resuscitators are a core emergency-care device for patients with breathing failure, so growth in this market tracks broader pressure on hospitals, ambulances and pre-hospital care systems. - The market’s expected rise to $1.68 billion by 2030 signals stronger demand for sterilizable, lower-cost ventilation tools as healthcare providers look to balance preparedness, safety and spending. - Rising respiratory disease, surgical volumes and aging populations are increasing the need for portable ventilation support in both emergency and perioperative settings.

What happened: - The Business Research Company projected the reusable manual resuscitators market will increase from $1.07 billion in 2025 to $1.17 billion in 2026, a 9.2% CAGR. - The report forecasts the market will reach $1.68 billion by 2030, growing at a 9.5% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow the fastest during the forecast period. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample report is available here: Download the sample report. - The full report is available here: View the full report.

The details: - Reusable manual resuscitators deliver manual positive-pressure ventilation to patients with breathing difficulty or respiratory failure. - The devices are designed for repeated use after sterilization. - Common use cases include resuscitation, anesthesia, patient transport and critical care in hospitals, ambulances and clinical settings. - The report links recent market growth to rising respiratory failure, more emergency hospital admissions, expansion of ambulance and trauma services, broader life support training and demand for affordable reusable devices. - The report says future growth will be supported by stronger demand for portable ventilation devices in pre-hospital care, greater emphasis on infection control, emerging-market critical care buildout, better ventilation accuracy and an aging population. - The CDC said the share of U.S. adults who had an asthma attack in the past year rose from 3.7% in 2022 to 3.8% in 2023. - The Aesthetic Society reported total surgical procedures increased 2.9% between 2022 and 2023. - The UK Office for National Statistics reported total healthcare spending rose 7.7% from 2024 to 2025.

Between the lines: - The market outlook reflects a shift toward reusable devices that can reduce long-term procurement costs while still meeting emergency readiness needs. - Growth in Asia-Pacific suggests expanding healthcare infrastructure and greater awareness of emergency respiratory care are becoming more important demand drivers. - The report’s emphasis on infection control and portability points to procurement priorities that extend beyond price alone.

What's next: - Demand is likely to stay tied to respiratory disease prevalence, surgical volume and healthcare investment. - Market expansion will depend on how quickly hospitals and emergency services adopt sterilizable equipment and upgrade critical care capacity. - The report says its 2026 edition now includes market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

The bottom line: - Reusable manual resuscitators are moving from a niche emergency device to a growing global market shaped by respiratory care demand, cost pressure and infection-control requirements.